109 related articles for article (PubMed ID: 11078910)
1. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y
Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910
[TBL] [Abstract][Full Text] [Related]
2. Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Lilling G; Nordenberg J; Rotter V; Goldfinger N; Peller S; Sidi Y
Cancer Invest; 2002; 20(4):509-17. PubMed ID: 12094546
[TBL] [Abstract][Full Text] [Related]
3. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
Teixeira C; Reed JC; Pratt MA
Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
[TBL] [Abstract][Full Text] [Related]
4. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
[TBL] [Abstract][Full Text] [Related]
6. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
Arteaga CL; Koli KM; Dugger TC; Clarke R
J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
[TBL] [Abstract][Full Text] [Related]
7. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Raha P; Thomas S; Thurn KT; Park J; Munster PN
Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
9. [Effect of tamoxifen on apoptosis and drug resistance of breast cancer cells in vitro].
Zheng J; Yao Z
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):55-7. PubMed ID: 11776601
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7.
Leung LK; Wang TT
Breast Cancer Res Treat; 1999 May; 55(1):73-83. PubMed ID: 10472781
[TBL] [Abstract][Full Text] [Related]
12. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
[TBL] [Abstract][Full Text] [Related]
13. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells.
Eck KM; Yuan L; Duffy L; Ram PT; Ayettey S; Chen I; Cohn CS; Reed JC; Hill SM
Br J Cancer; 1998 Jun; 77(12):2129-37. PubMed ID: 9649124
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
Leung LK; Wang TT
Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
[TBL] [Abstract][Full Text] [Related]
16. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S
Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367
[TBL] [Abstract][Full Text] [Related]
18. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
19. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K
Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
